Effect of Paricalcitol on Left Ventricular Mass and Function in CKD—The OPERA Trial-Reference-Cited by-同舟云学术

Effect of Paricalcitol on Left Ventricular Mass and Function in CKD—The OPERA Trial

Published:2013-09-19 Issue:1 Volume:25 Page:175-186
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Wang Angela Yee-Moon,Fang Fang,Chan John,Wen Yue-Yi,Qing Shang,Chan Iris Hiu-Shuen,Lo Gladys,Lai Kar-Neng,Lo Wai-Kei,Lam Christopher Wai-Kei,Yu Cheuk-Man

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference48 articles.

1. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

2. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease

3. 1,25-Dihydroxyvitamin D3 receptors identified in the rat heart.;Walters;J Mol Cell Cardiol,1986

4. Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat

5. Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects.;Weishaar;Am J Physiol,1987

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation;Journal of Nephrology;2024-09-02

2. Vitamin D therapy in chronic kidney disease: a critical appraisal of clinical trial evidence;Clinical Kidney Journal;2024-07-18

3. Association of 1,25 dihydroxyvitamin D with left ventricular hypertrophy and left ventricular diastolic dysfunction in patients with chronic kidney disease;PLOS ONE;2024-05-09

4. Extended-Release Calcifediol: A Data Journey from Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism;Nephron;2024-04-24

5. Vitamin D and cardiovascular diseases: A narrative review;Journal of Family Medicine and Primary Care;2024-04